Cargando…
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
Oncological diseases have currently reached an epidemic scale, especially in industrialized countries. Such a situation has prompted complex studies in medicinal chemistry focused on the research and development of novel effective anticancer drugs. In this review, the data concerning new 4-thiazolid...
Autores principales: | Roszczenko, Piotr, Holota, Serhii, Szewczyk, Olga Klaudia, Dudchak, Rostyslav, Bielawski, Krzysztof, Bielawska, Anna, Lesyk, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654980/ https://www.ncbi.nlm.nih.gov/pubmed/36361924 http://dx.doi.org/10.3390/ijms232113135 |
Ejemplares similares
-
Development of Novel Pyridine-Thiazole Hybrid Molecules as Potential Anticancer Agents
por: Ivasechko, Iryna, et al.
Publicado: (2022) -
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
por: Szewczyk-Roszczenko, Olga Klaudia, et al.
Publicado: (2023) -
Multi-Targeting Anticancer Activity of a New 4-Thiazolidinone Derivative with Anti-HER2 Antibodies in Human AGS Gastric Cancer Cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2023) -
Synthesis and Anticancer Activity Evaluation of 5-[2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-thiazolidinones
por: Buzun, Kamila, et al.
Publicado: (2021) -
An Overview of the Importance of Transition-Metal Nanoparticles in Cancer Research
por: Szewczyk, Olga Klaudia, et al.
Publicado: (2022)